• Home
  • About Us
    • Company Profile
    • Corporate Structure
    • Milestones
  • Core Business
    • R&D and Production Base
      • Zhuhai R&D and Production Base
      • Kunming R&D and Production Base
      • Global Sales Network
    • Chinese Medicine Development
      • Chinese Medicine R&D
      • Chinese Medicinal Materials
      • Decoction Slices
    • Biomedical Technology and Products
      • Tianda Products
      • Pipeline
    • Quality Healthcare Services
  • Investor Relations
    • Corporate Information
    • Corporate Governance
    • Announcements & Circulars
    • Financial Statements
    • Shares and Details
    • Investor Calendar
    • Investor Enquiries
    • Email Alerts
    • Notices (Replacement of Lost Share Certificates)
    • Dissemination of Corporate Communications
  • Sustainability
    • Our Sustainable Development
    • ESG Report
  • Careers
    • Wort At Tianda
    • Recruitment
      • Vacancies
      • Internship Programmes
      • Trainee Programmes
  • Media Centre
    • Press Releases
    • Media Coverage
    • Contact Us
    • 繁
    • 简
繁 简
  • About Us
    • Company Profile
    • Corporate Structure
    • Milestones
  • Core Business
    • R&D and Production Base
      • Zhuhai R&D and Production Base
      • Kunming R&D and Production Base
      • Global Sales Network
    • Chinese Medicine Development
      • Chinese Medicine R&D
      • Chinese Medicinal Materials
      • Decoction Slices
    • Biomedical Technology and Products
      • Tianda Products
      • Pipeline
    • Quality Healthcare Services
  • Investor Relations
    • Corporate Information
    • Corporate Governance
    • Announcements & Circulars
    • Financial Statements
    • Shares and Details
    • Investor Calendar
    • Investor Enquiries
    • Email Alerts
    • Notices (Replacement of Lost Share Certificates)
    • Dissemination of Corporate Communications
  • Sustainability
    • Our Sustainable Development
    • ESG Report
  • Careers
    • Wort At Tianda
    • Recruitment
      • Vacancies
      • Internship Programmes
      • Trainee Programmes
  • Media Centre
    • Press Releases
    • Media Coverage
    • Contact Us

2021
  • Select Year
    1. 2022
    2. 2021
    3. 2020
    4. 2019
    5. 2018
    6. 2017
    7. 2016
    8. 2015
    9. 2014
    10. 2013
    11. 2012
  • 10.11.2021

    天大與中基長壽訂3年框架戰略合作(明報) (Chinese version only)

  • 20.09.2021

    TDMall on Cloud lauded for bringing healthcare within reach

  • 13.09.2021

    尖沙咀天大館於上周四正式開業 (Chinese version only) (HKET)

  • 13.09.2021

    天大藥業尖沙咀天大館開業 (Chinese version only) (頭條日報)

  • 24.03.2021

    TDMall opens its third Traditional Chinese Medicine clinic in Sydney (The Weekly Times)

  • 16.03.2021

    全球第三家天大館落子澳大利亞悉尼 (Chinese version only) (華富財經)

  • 16.03.2021

    全球第三家天大館落子澳大利亞悉尼 (Chinese version only) (新浪新聞)

  • 16.03.2021

    全球第三家天大館落子澳大利亞悉尼 (Chinese version only) (PC Home)

  • 16.03.2021

    全球第三家天大館落子澳大利亞悉尼 (Chinese version only) (經濟通)

  • 16.03.2021

    全球第三家天大館落子澳大利亞悉尼 (Chinese version only) (澳洲新報)

  • 16.03.2021

    The third TDMall in the world opened in Sydney, Australia (Yahoo! Singapore)

  • 16.03.2021

    The third TDMall in the world opened in Sydney, Australia (ETNet)

  • 16.03.2021

    The third TDMall in the world opened in Sydney, Australia (Bloomberg)

  • 16.03.2021

    The third TDMall in the world opened in Sydney, Australia (Asiaone)

  • 16.03.2021

    The third TDMall in the world opened in Sydney, Australia (ACN Newswire)

  • 04.03.2021

    天大藥業收購小兒清熱止咳顆粒劑 豐富產品組合並持續完善中醫藥全產業鏈佈局 (Chinese version only) (新浪)

  • 04.03.2021

    天大藥業收購小兒清熱止咳顆粒劑 豐富產品組合並持續完善中醫藥全產業鏈佈局 (Chinese version only) (PC HOME)

  • 04.03.2021

    Acquiring Xiaoer Qingre Zhike granule, Tianda Pharmaceuticals continues to broaden its product mix and perfect its Chinese medicine whole industry chain layout (Asiaone)

  • 04.03.2021

    Acquiring Xiaoer Qingre Zhike granule, Tianda Pharmaceuticals continues to broaden its product mix and perfect its Chinese medicine whole industry chain layout (Etnet)

  • 04.03.2021

    Acquiring Xiaoer Qingre Zhike granule, Tianda Pharmaceuticals continues to broaden its product mix and perfect its Chinese medicine whole industry chain layout (ACN Newswire)

關注天大藥業:

  • About Us
    Company Profile Corporate Structure Milestones
  • Core Business
    R&D and Production Base Chinese Medicine Development Biomedical Technology and Products Quality Healthcare Services
  • Investor Relations
    Corporate Information Corporate Governance Announcements & Circulars Financial Statements Shares and Details Investor Calendar Investor Enquiries Email Alerts Notices (Replacement of Lost Share Certificates) Dissemination of Corporate Communications
  • Sustainability
    Our Sustainable Development ESG Reports
  • Careers
    Wort At Tianda Recruitment
  • Media Centre
    Press Releases Media Coverage Contact Us

Email AlertsPlease enter your email address

關注天大藥業:

  • Hong Kong Headquarters Level 24, CITIC Tower, No. 1 Tim Mei Avenue, Central, Hong Kong

    Tel: +852 2545 3313

    Fax: +852 2541 6558

    Email: info@tianda.com

  • China, Regional Headquarters Level 28, Block C, Tian An International Building, 3012 Renmin Road South, Shenzhen, China

    (Postal code: 518001)

    Tel: +86 755 8228 3533

    Fax: +86 755 8228 9636

  • Australia, Regional HeadquartersSuite 3.03, Level 3, Macquarie Corporate Centre, 2 Banfield Road, Macquarie Park, NSW 2113, Australia

    Tel: +61 2 9251 9001

    Fax: +61 2 9251 7688

© Tianda Pharmaceuticals Limited. All Rights Reserved.
Disclaimer | Important Notice